-+ 0.00%
-+ 0.00%
-+ 0.00%
NurExone's ExoPTEN Promotes Human Neuron Regrowth in Lab Study
Share
Listen to the news
NurExone's ExoPTEN Promotes Human Neuron Regrowth in Lab Study
  • NurExone Biologic today announced laboratory results showing its lead candidate, ExoPTEN, promoted regrowth of severed nerve fibers in human motor neurons.
  • Treated cells showed greater nerve-fiber growth than untreated cells or control treatments; ExoPTEN also reduced expression of a gene that inhibits regeneration.
  • The findings add human-cell evidence to preclinical studies supporting development for spinal cord and optic nerve injuries.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NurExone Biologic Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611180830PRIMZONEFULLFEED9880358) on November 18, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending